Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 2/20 | 0.41 |
| ▸ | FBP1 | P09467 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL509572 | 1.00 | CYP3A4 (0.71) | CYP3A4CYP2C9RECQLAKR1C3ALDH1A1 | |
| SCHEMBL27842426 | 1.00 | CYP3A4 (0.71) | CYP3A4CYP2C9RECQLAKR1C3ALDH1A1 | |
| SCHEMBL22147 | 0.98 | CYP3A4 (0.73) | CYP3A4CYP2C9RECQLAKR1C3ALDH1A1 | |
| SCHEMBL8405958 | 0.96 | CYP3A4 (0.71) | CYP3A4CYP2C9RECQLAKR1C3ALDH1A1 | |
| SCHEMBL7265807 | 0.96 | CYP3A4 (0.71) | CYP3A4CYP2C9RECQLAKR1C3ALDH1A1 | |
| SCHEMBL23573648 | 0.92 | CYP3A4 (0.65) | CYP3A4CYP2C9RECQLAKR1C3ALDH1A1 | |
| SCHEMBL28791435 | 0.88 | CYP3A4 (0.60) | CYP3A4CYP2C9RECQLAKR1C3ALDH1A1 | |
| SCHEMBL27973887 | 0.87 | CYP2C9 (0.58) | CYP3A4CYP2C9RECQLAKR1C3ALDH1A1 | |
| SCHEMBL28791434 | 0.87 | CYP3A4 (0.58) | CYP3A4CYP2C9RECQLAKR1C3ALDH1A1 | |
| SCHEMBL27973886 | 0.87 | CYP2C9 (0.58) | CYP3A4CYP2C9RECQLALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116457351-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2025-04-22 | — | — | CN | disclosed |
| CN-119798178-A | Novel compound and organic light emitting device using the same | 株式会社LG化学 | 2025-04-11 | — | — | CN | disclosed |
| CN-119775269-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2025-04-08 | — | — | CN | disclosed |
| CN-119546593-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2025-02-28 | — | — | CN | disclosed |
| CN-119095841-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-12-06 | — | — | CN | disclosed |
| CN-119054439-A | Organic light emitting device | 株式会社LG化学 | 2024-11-29 | — | — | CN | disclosed |
| US-20240357925-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2024-10-24 | — | — | US | disclosed |
| WO-2024196061-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2024-09-26 | — | — | WO | disclosed |
| WO-2024196207-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2024-09-26 | — | — | WO | disclosed |
| WO-2024167337-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2024-08-15 | — | — | WO | disclosed |
| WO-2020141949-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2020-07-09 | — | — | WO | disclosed |
| WO-2020085740-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE USING SAME | 주식회사 엘지화학 | 2020-04-30 | — | — | WO | disclosed |
| EP-2628738-A1 | Heterocyclic substituted pyridine derivatives and antifungal agent containing same | Eisai R&D Management Co., Ltd. (JP) | 2013-08-21 | — | — | EP | disclosed |
| EP-1944303-B1 | PYRIDINE DERIVATIVE SUBSTITUTED BY HETEROCYCLE AND FUNGICIDE CONTAINING THE SAME | EISAI R&D MAN CO LTD (JP) | 2013-08-21 | — | — | EP | disclosed |
| US-8507530-B2 | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2013-08-13 | — | — | US | disclosed |
| US-8102113-B2 | Quinoxaline-containing compounds and polymers thereof | FUJI XEROX CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| EP-2141171-A1 | PYRIDINE DERIVATIVE SUBSTITUTED WITH HETEROCYCLE AND PHOSPHONOAMINO AND ANTIFUNGAL AGENT CONTAINING THE SAME | Eisai R&D Management Co., Ltd. (JP) | 2010-01-06 | — | — | EP | disclosed |
| US-20090082403-A1 | PYRIDINE DERIVATIVES SUBSTITUTED BY HETEROCYCLIC RING AND PHOSPHONOAMINO GROUP, AND ANTI-FUNGAL AGENT CONTAINING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-03-26 | — | — | US | disclosed |
| US-20080306239-A1 | QUINOXALINE-CONTAINING COMPOUNDS AND POLYMERS THEREOF | FUJI XEROX CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
| EP-1944303-A1 | PYRIDINE DERIVATIVE SUBSTITUTED BY HETEROCYCLE AND FUNGICIDE CONTAINING THE SAME | Eisai R&D Management Co., Ltd. (JP) | 2008-07-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082403-A1 | PYRIDINE DERIVATIVES SUBSTITUTED BY HETEROCYCLIC RING AND PHOSPHONOAMINO GROUP, AND ANTI-FUNGAL AGENT CONTAINING SAME | ERG28, H1-2, H1-3 | CYP3A4 983/4885CYP2C9 1890/4885RECQL 2104/4885 |
| US-20080306239-A1 | QUINOXALINE-CONTAINING COMPOUNDS AND POLYMERS THEREOF | ARL1, NMRAL1, PDXK | CYP3A4 1635/4885CYP2C9 1670/4885RECQL 20/4885 |
| US-20240357925-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | NR2E3, CRY1, CRY2 | CYP3A4 739/4885CYP2C9 1123/4885RECQL 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.